Production of the HIV-suppressive chemokines CCL3/MIP-1alpha and CCL22/MDC is associated with more effective antiretroviral therapy in HIV-infected children.

MLA

Lambert, John S., et al. “Production of the HIV-Suppressive Chemokines CCL3/MIP-1alpha and CCL22/MDC Is Associated with More Effective Antiretroviral Therapy in HIV-Infected Children.” The Pediatric Infectious Disease Journal, vol. 26, no. 10, Oct. 2007, pp. 935–44. EBSCOhost, https://doi.org/10.1097/INF.0b013e31812714db.

APA

Lambert, J. S., Machado, E. S., Watson, D. C., Sill, A. M., Lim, J. K., Charurat, M., Cunha, S. M., Afonso, A. O., Oliviera, R. H., Tanuri, A., & DeVico, A. L. (2007). Production of the HIV-suppressive chemokines CCL3/MIP-1alpha and CCL22/MDC is associated with more effective antiretroviral therapy in HIV-infected children. The Pediatric Infectious Disease Journal, 26(10), 935–944. https://doi.org/10.1097/INF.0b013e31812714db

Chicago

Lambert, John S, Elizabeth S Machado, Douglas C Watson, Anne M Sill, Jean K Lim, Manhattan Charurat, Silvia M Cunha, et al. 2007. “Production of the HIV-Suppressive Chemokines CCL3/MIP-1alpha and CCL22/MDC Is Associated with More Effective Antiretroviral Therapy in HIV-Infected Children.” The Pediatric Infectious Disease Journal 26 (10): 935–44. doi:10.1097/INF.0b013e31812714db.